x
Filter:
Filters applied
- Gene Regulation
- Retraction ChapterRemove Retraction Chapter filter
- Lecka-Czernik, BeataRemove Lecka-Czernik, Beata filter
- Sanchez, Edwin RRemove Sanchez, Edwin R filter
- Journal of Biological ChemistryRemove Journal of Biological Chemistry filter
Gene Regulation
1 Results
- THIS ARTICLE HAS BEEN WITHDRAWNOpen Access
Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2)
Journal of Biological ChemistryVol. 291Issue 47p24475–24486Published online: November 1, 2016- Lance A. Stechschulte
- Chunxi Ge
- Terry D. Hinds Jr.
- Edwin R. Sanchez
- Renny T. Franceschi
- Beata Lecka-Czernik
Cited in Scopus: 18Peroxisome proliferator-activated receptor γ (PPARγ) and runt-related transcription factor 2 (RUNX2) are key regulators of mesenchymal stem cell (MSC) differentiation toward adipocytes and osteoblasts, respectively. Post-translational modifications of these factors determine their activities. Dephosphorylation of PPARγ at Ser-112 is required for its adipocytic activity, whereas phosphorylation of RUNX2 at serine 319 (Ser-319) promotes its osteoblastic activity. Here we show that protein phosphatase 5 (PP5) reciprocally regulates each receptor by targeting each serine.